ETIOLOGY, PATHOGENESIS, AND TREATMENT METHODS OF UTERINE LEIOMYOMA
Keywords:
Leiomyoma, uterine tumor, hormonal imbalance, myomectomy, embolization, reproductive health.Abstract
Uterine leiomyoma is the most common benign tumor in women, originating from the smooth muscle tissue of the uterus. This article explores the etiology, pathogenesis, clinical manifestations, diagnostic methods, as well as current conservative and surgical treatment options. Special attention is given to the impact on reproductive health and modern therapeutic strategies.
References
1. Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–1355.
2. Stewart EA, Laughlin-Tommaso SK, Catherino WH, et al. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16043.
3. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in Black and White women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107.
4. Practice Bulletin No. 228: Management of Symptomatic Uterine Leiomyomas. Obstet Gynecol. 2021;137(6):e100–e115.
5. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for determining the presence, number, and position of uterine myomas. Fertil Steril. 2001;76(2): 221–227.
6. Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346(8976):671–672.
